即使在酪氨酸激酶抑制剂时代，也应识别慢性髓性白血病的新生加速期。
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
机构信息
Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
出版信息
Am J Hematol. 2024 Apr;99(4):763-766. doi: 10.1002/ajh.27229. Epub 2024 Feb 5.
PMID:38317312
Abstract
Overall survival of patients classified according to the European LeukemiaNet 2020 classification. Chronic phase (CP), accelerated phase (AP), blast crisis (BC), low risk (LR), intermediate risk (IR), high risk (HR).
摘要
根据欧洲白血病网络 2020 分类的患者总生存情况。慢性期（CP）、加速期（AP）、急变期（BC）、低危（LR）、中危（IR）、高危（HR）。
Zotero 插件